News
Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.
Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...
Myeloma Trial Results Spark Talk of 'Potential Cure' — One-third of patients alive and progression-free 5 or more years after a single infusion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results